Dr. Stephen Mott - Director of Pediatric Neurology; Medical Director, Child Development Center at Georgetown University; Executive Director, Ahead with Autism Foundation,Washington, DC, US
CURRICULUM VITAESTEPHEN HAMILTON MOTT, M.D.
PERSONAL INFORMATION:
Office Address: Division of Pediatric Neurology
Department of Pediatrics
Georgetown University Medical Center-2PHC
3800 Reservoir Rd., NW
Washington, DC 20007
Date of Birth: May 9, 1956
Place of Birth: Syracuse, New York
Citizenship: U.S.A.
CERTIFICATION:
1987 FMGEMS [ECFMG]
1990 FLEX
1993 American Board of Pediatrics-Board Certified
1997 American Board of Psychiatry and Neurology with special qualification in Child Neurology-Board Certified
2000 American Board of Pediatrics-Board Re-Certification
2004 American Board of Psychiatry and Neurology; Neurodevelopmental Pediatrics-Board Certified
2007 American Board of Psychiatry and Neurology with special qualification in Child
Neurology-Board Re-Certified
2007 American Board of Pediatrics-Board Second Re-Certification
EDUCATION:
1974-1978 A.B., Biology with concentration in Music
Grinnell College
Grinnell, Iowa
1979-1982 Premedical Studies and Chemistry
School of General Studies
Columbia University
New York, New York
1982-1987 MD, Doctor of Medicine
Faculté Libre De Medecine
Université Catholique
Lille, FRANCE
Postgraduate Training and Fellowships
1987-1988 Intern in Pediatrics
Maine Medical Center
Portland, Maine
1988-1990 Resident in Pediatrics
Maine Medical Center
Portland, Maine
1990-1991 Resident in Neurology
George Washington University
George Washington University Hospital
Washington, DC
1991-1993 Child Neurology Fellow
Children’s National Medical Center
George Washington University Medical School
Washington, DC
1993-1994 Post Doctoral Fellow in Developmental Cognitive Neurology
Kennedy-Krieger Institute
Johns Hopkins University Medical School
Appointments
1993-1994 Instructor
Departments of Pediatrics and Neurology
George Washington University Medical School
Washington, DC
1994-1997 Assistant Professor
Departments of Neurology and Pediatrics
George Washington University Medical School
Washington, DC
1994-1997 Guest Researcher
Epilepsy Research Branch
National Institute of Neurological
Disease and Stroke
National Institutes of Health
1996-1997 Special Volunteer, Clinical Brain
Disorders Branch
National Institutes of Mental Health
St. Elizabeth’s Hospital Campus
1997-2000 Assistant Professor
Departments of Pediatrics, Neurology and Psychiatry
George Washington University Medical School
2000-present Associate Professor
Department of Pediatrics
Georgetown University Medical School
2004-present Associate Professor (Secondary Appointment)
Department of Neurology
Georgetown University Medical School
PROFESSIONAL EXPERIENCE:
1979-1982 Electron Microscopy Research Technician
Department of Pulmonary Medicine
Columbia College of Physician and Surgeons
Columbia-Presbyterian Hospital
New York, New York
1994-1997 Coordinator, Child Neurology Fellowship Program
Department of Neurology
Children’s National Medical Center
Washington, DC
1995-1997 Director, Developmental Cognitive Neurology
Department of Neurology
Children’s National Medical Center
Washington, DC
1996-1997 Director, Neurology Consultative Services
Neuropsychiatric Research Hospital
National Institutes of Mental Health
St. Elizabeth’s Hospital Campus
1997-2000 Director, Developmental Pediatrics Program
Children’s National Medical Center
Washington, DC
2000 Co-Director, Neurology Consultative Services
District of Columbia Commission on Mental Health
St. Elizabeth’s Hospital
Washington, DC
2000-Present Division Chief, Pediatric Neurology and Neurodevelopmental Pediatrics
Director, Center for Neurocognitive and Neurodevelopmental Services
Department of Pediatrics
Georgetown University Medical Center
PROFESSIONAL SOCIETIES:
Organizations:
2000-Present Executive Director
Ahead with Autism
Veronica Bird Charitable Foundation
HONORS:
1987 Maxima Cum Laude
Faculté Libre de Medicine
Universite Catholique
Lille, France
1993 Mark Platt Outstanding Neurology Resident Award
Department of Neurology
George Washington University Medical School
Washington, DC
1996 Physicians’ Recognition Award
Children’s National Medical Center
BIBLIOGRAPHY
Original Papers:
1. Cantor JO, Cerreta JM, Osman M, Mott SH, Mandl I, and Turino GM. Glycosaminoglycan synthesis in bleomycin-induced pulmonary fibrosis: biochemistry and autoradiography. Proc Soc Exp Biol Med 174(2): 172-81, 1983.
2. Marro P, Dransfield D, Mott SH, Allan W. Posthemorrhagic hydrocephalus: Use of an intravenous-type catheter for cerebrospinal fluid drainage. AJDC 145:1141-1146, 1991.
3. Mott SH, Bodenstiener JB and Allan WC. The cavum septi pellucidi in term and preterm newborn infants. J Child Neurol 7(1): 35-38 1992.
4. Pranzatelli MR, Mott SH, Pavlakis S, Conry JA, Tate ED. Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder. Pediatr Neurol 10: 131-140, 1994.
5. Mott SH, Packer RJ, Solden SJ. Neurologic manifestations of cocaine exposure in childhood. Pediatrics 93(1):557-560, 1994.
6. Mott SH, Packer RJ, Vezina LG, Kapur S, Dinndorf PA, Conry JA, Pranzatelli MR, Quiones RR. Encephalopathy with parkinsonian features in children following bone marrow transplantation treated with high-dose amphotericin B. Neurology 37: 810-814, 1995.
7. Hertz-Pannier L; Gaillard WD; Mott SH; Cuenod Ca; Bookheimer SY; Weinstein S; Conry J; Papero PH; Schiff SJ; LeBihan D; Theodore WH: Noninvasive assessment of language dominance in children and adolescents with functional MRI: a preliminary study. Neurology 48: 1003-1012, 1997.
8. Geschwind D, Cummings J, Hollander E, DiMauro S, Cook E, Lombard J, Stefanatos G, Sprouse C, Jensen P, Mott SH, Zimmerman A, Tuchman R, Chagani D, Chez M, Lewine J, Iversen L, Kornblum H, Griesbach A, Miller B, Robinson R, Trauner D, Nespeca M, Stubbs G, Iverson P, Shestok J, Bolte E, Levine H, Levine L, Toedtman M. Autism Screening and Diagnotic Evaluation: CAN Consensus Statement. CNS Spectrum 1998; 3(3): 40-49.
Abstracts:
1. Cantor JO, Cerreta JM, Osman M, Mott SH, Mandl I, and Turino GM. Autoradiographic study of glycosaminoglycan synthesis in bleomycin-induced pulmonary fibrosis. Federation Proceddings 40: 595, 1981.
2. Osman M, Keller S, Cantor J, Cerreta J, Mott S, Turino GM, and Mandl I. Inhibition of lung elastin resynthesis in hamsters after sequential administration of elastase and trypsin. Federal Proceedings 41: 488, 1982.
3. Mott SH, Pranzatelli MR, Pavlakis SG, Tate ED, Jaffe D, Conry J. Clinical spectrum of juvenile parkinsonism: A reversible disorder. Ann of Neurology 32: 442, 1992.
4. Mott SH, Packer RJ, Vezina LG, Dinndorf PA, Quinones RR. Encephalopathy with parkinsonian features in children following bone marrow transplantations treated with high dose amphotericin B. Neurology 43: 206, 1993.
5. Mott SH, Samango-Sprouse CA, Vezina LG, Tifft CJ, Stern HJ, Saal HM, Packer RJ, Rosenbaum KN. Nuerofibromatosis type 1 (NF1): correlates between neurodevelopmental profile, hypotonia, and findings on magnetic resonance imaging (MR) in young children. Neurology 44: A144-145, 1994.
6. Gaillard WD, Hertz-Pannier L, Mott SH, Weinstein S, Conry J, Kolodgie M, Theodore WH, LeBihan D. Identification of cortical language areas using 1.5 T functional MRI in children with epilepsy. Ann Neurol 36(3): 504, 1994.
7. Mott SH, Brasseux CO, Samango-Sprouse CA, Vezina LG, Packer RJ, Rosenbaum KN. Clinical algorithmic analysis of high intensity T2-weighted signals (UBO) on magnetic resonance imaging (MR) in young children with neurofibromatosis type 1 (nf-1) correlating with cognitive scores. Ann Neurol 36(3):539, 1994.
8. Mott SH, Skryia PA, Baumgardner TL, Reiss Al, Hofman K, Denckla MB. Neurofibromatosis type 1: Association between volumes of T2 weighted high intensity signals (UBO’s) on magnetic resonance imagine and impaired performance on judgement of line orientation. Ped Neurol 121(2):88, 1994.
9. Mott SH, Mazzoco M, Reiss AL, Hofman K, Melham XL, Denckla MB. Neurofibromatosis type 1: correlation between volumes of T2 weighted high intensity signals (UBO’s) within neural pathways and impaired performance on judgement of line orientation. Ann Neurol 38(3):509, 1995.
10. Mott, SH, Weinstein SL, Conry JA, Kenworthy LE, Lockwood S, Wagner A, Packer RJ. Pervasive developmental disorder/autism (pdd/aut) vs landae kleffner syndrome (lks): steroid responsive encephalopathy characterized by language and social interactive impairment. Ann Neurol 40(2):332, 1996.
11. Mott SH, Baumgartner T, Vezina LG, Abrams MT, Rubin M, Reiss AL, and Denckla MB. Neurofibromatosis type 1 (nf-1): corpus callosum (cc) enlarged beyond megencephaly. Ann Neurol 40(2):325, 1996.
12. Mott SH, Weiss IP. Relationship between EEG abnormalities and cortical auditory evoked potentials (CAEP) in children with severe language deficits. Ann Neurol 40(2): 332, 1996.
Participant in video productions, “Different Shades of Autism” 1999-2000. The video was done in conjunction with the Veronica Bird Charitable Foundation, Children’s National Medical Center, Kennedy-Kreiger Institute and University of California at Irvine.
Thesis: Mott SH. “Frontal lobe dysfunction in ADHD: Methylphenidate medication and neuropsycholgical study.” Presented June 1987 at the Faculté Libre de Medecine, Lille, France.
Invited Lectureships:
Local and Regional Guest Lectureships:
Invited speaker for the Children’s National Medical Center’s Neurology Departments annual Update
Course entitled, “Treatments for Attention Deficit Disorder,” Washington, DC, Spring 1995.
Invited speaker for the Children’s National Medical Center’s Neurology Departments annual Update
Course entitled, “Autism and Landau Kleffner Syndrome,” Washington, DC, Spring 1996.
Yearly invited speaker for the Friends of Children with Downs Syndrome of Northern Virginia entitled,
“Updates on Neurologist’s Approach Pharmacological Management of Behavioral Disorders,” Fairfax,
Virginia, annually since the Spring 1996.
Invited speaker for the Children’s National Medical Center’s Advances in Pediatrics: Educational and
Scientific Forum, entitled, “CNS Deviation in ADHD, OCD, and Tourette’s Syndrome,” Washington,
DC, Spring 1996.
Invited speaker for the National Institutes of Mental Health Grand Rounds at St. Elizabeth’s Hospital
Campus, entitled, “Autism: A Developmental Cognitive Neurologist’s Perspective,” Washington, DC, Fall
1996.
Keynote speaker for the Mental Health Association of Prince Georges County, Inc on Attention Deficit
Disorder ADD/ADHD: Coping in the 90’s entitled, “State of the Art in ADHD Research,” Burtonsville,
Maryland, Fall 1996.
Invited speaker for the Children’s National Medical Center’s Neurology Departments annual Update
Course entitled, “Medical Management of Autism,” Washington, DC, Spring 1997.
Invited speaker for the Children’s National Medical Center’s Neurology Departments annual Update
Course entitled, “Genetics of Autism and Learning Disabilities,” Washington, DC, Spring 1998.
Keynote speaker for the opening of the Midatlantic Chapter of Cure Autism Now entitled,
“Electroencephalography: Use in the Work-up and Treatment of Autism,” Rockville, Maryland, January
1999.
Invited speaker for the Children’s National Medical Center’s Neurology Departments annual Update
Course entitled, “Medical Treatment of Attention Deficit Disorder,” Washington, DC, Spring 2000.
Invited lecturer for the Interdisciplinary Council on Developmental & Learning Disorders Course on
Developmental Disabilities: Autistic Spectrum Disorder entitled “Update on the Neurobiological
Treatments of Autism,” Crystal City, Virginia, Spring 2000.
Invited lecturer for the Early Intervention Workshop, Multiple Approaches-Multiple Cultures entitled,
“Autism I,: Galluadet University, Washington, DC, Spring 2000.
Invited lecturer for the F.E.A.T. Organization, Biomedical Treatments of the Autistic Spectrum Disorders,
Holy Cross Hospital, Silver Spring, Maryland, Summer 2000.
Invited lecturer for the Georgetown University Children’s Medical Center Pediatric Grand Rounds,
“Autism: A New Model Approach to Developmental Disorders,” Washington, DC, Fall 2000.
Invited speaker for the St. Elizabeth’s Hospital Psychiatry Grand Rounds, Office of Continuing Medical
Education, “Childhood Autism: A Developmental Cognitive Neurologist’s Perspective,” Washington, DC,
Spring 2001.
Invited lecturer for the Georgetown University Children’s Medical Center Pediatric Grand Rounds,
“ADHD: Differential Diagnosis of Attentional Problems” Washington, DC, Spring 2002.
Invited lecturer for the Autism Society of Maryland and the Montgomery County Public Schools, Biomedical Treatments of the Autistic Spectrum Disorders, Carl Sandburg School, Rockville, Maryland, Spring 2004.
Invited lecturer for the Washington County Public Schools, Brain Function in Different Learning Styles,
Fountaindale Elementary School, Hagerstown, Maryland, Fall 2005.
Invited lecturer for the Georgetown University Children’s Medical Center Pediatric Grand Rounds,
“Autism: Early Identification of Target Symptoms” Washington, DC, Spring 2006.
Invited lecturer for the Georgetown University Children’s Medical Center Pediatric Grand Rounds,
“Autism Update” Washington, DC, Fall 2007.
National Guest Lectureships:
Invited speaker for the Cure Autism Now Foundation (C.A.N.) Think Tank on Autism entitled, “Steroid
Responsive Encephalopathy characterized by Language and Social Interactive Impairments,” Redondo
Beach, California, Spring 1997.
Invited speaker for the Autistic Services, Inc. on “Discovering Abilities…Connecting Worlds” entitled,
“Pharmacological Interventions: A Developmental Cognitive Neurologist’s Perspective,” Buffalo, New
York, Fall 1997.
Invited speaker for the Interdisciplinary Council on Developmental & Learning Disorders on Approaches
to Developmental and Learning Disorders in Infants and Children: Theory & Practice entitled,
“Pharmacological Management of Autism,” Rockville, Maryland, Fall 1997.
Invited speaker at first conference by the Van Beisbrouk Foundation entitled “ADHD: A Developmental
Cognitive Neurologist’s Perspective,” Fort Lauderdale, Florida, March 1998.
Invited speaker for the Learning Disabilities Association, National Meeting, entitled “ADHD: Differential
Diagnosis: the Developmental Cognitive Neurologist’s Perspective”, Washington, DC, March 1998.
Invited speaker for the National Academy of Neuropsychology, National Meeting, “Medical Interventions
for the Treatment of Autism,” Washington, DC, Nov. 1998.
Invited speaker for the Federal Intra-agency Commission, “Pediatric Neurologist Perspective for the Early
Identification and Work up of Autism”, Washington DC, 2004.
Invited lecturer at the Seattle University, School of Nursing, “Autism”, Seattle Washington February 2007.
International Guest:
Participant in the International Collaborative Autism sib-pair Study group, (P.A.R.I.S.) on “Genetics and
Autism,” Paris, France, Spring 1997.
Invited speaker for Autism Society of Brazil, “Neurologist’s Approach to the Evaluation and Treatment of
Autism”, San Pablo, Brazil, Summer 2002.
Grand Rounds Speaker, University of Medicine, “Autism”, Rio De Janeiro, Brazil, Summer 2002.
Workshop on Early Identification of Autism. Georgetown, Cayman Islands, Winter 2004.
Previous page: Dr. Michael S. Jaffee
Next page: Dr. Anthony Campinell, VA Director, Therapeutic Employment, Office of Mental Health, US Veterans Health